Standard BioTools Inc.
LAB
$1.29
-$0.04-3.01%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -33.46M | -26.03M | -34.07M | -26.94M | -- |
| Total Depreciation and Amortization | 3.99M | 4.17M | 3.95M | 6.37M | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -2.51M | -- |
| Total Other Non-Cash Items | 7.72M | 7.17M | 8.05M | 5.90M | -- |
| Change in Net Operating Assets | 1.08M | -15.60M | 8.02M | -10.69M | -- |
| Cash from Operations | -20.67M | -30.28M | -14.06M | -27.87M | -39.05M |
| Capital Expenditure | -1.89M | -5.05M | -3.38M | -2.26M | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -1.39M | 0.00 | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 29.39M | 19.68M | 30.49M | -28.63M | -- |
| Cash from Investing | 27.51M | 14.63M | 25.73M | -30.88M | 50.26M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -55.00M | 0.00 | -- |
| Issuance of Common Stock | 308.00K | -- | 525.00K | 68.00K | -- |
| Repurchase of Common Stock | -200.00K | -46.00K | -45.00K | -70.00K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 0.00 | 0.00 | -- |
| Cash from Financing | 108.00K | -46.00K | -54.52M | -2.00K | -28.36M |
| Foreign Exchange rate Adjustments | 788.00K | 357.00K | -267.00K | -408.00K | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 7.73M | -15.35M | -43.12M | -59.16M | -17.24M |